October 03, 2011
A New Jersey federal judge on Thursday dismissed a derivative shareholder suit against health giant Johnson & Johnson, ruling the complaint lacked facts to show that J&J executives ignored warning signs about drug recalls, kickback schemes and other damaging incidents.
July 21, 2011
Johnson & Johnson responded Monday to a slew of shareholder derivative actions in New Jersey federal court with a report stating the company's board of directors did not breach its duties and ignore warning signs of product recalls and illegal kickbacks and bribes.